Mar 31, 2021, 14:05
News
IR
English
Regulatory
MAR
Corporate Information
Sales
Order
Mar 31, 2021, 14:05
News
IR
Swedish
Regulatory
MAR
Corporate Information
Sales
Order
Mar 15, 2021, 09:55
News
PR
Swedish
Mar 11, 2021, 12:05
News
IR
Swedish
Corporate Information
Other Corporate Information
Mar 11, 2021, 12:05
News
IR
English
Corporate Information
Other Corporate Information
Feb 18, 2021, 12:50
News
IR
English
Corporate Information
Other Corporate Information
Feb 17, 2021, 13:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Feb 17, 2021, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Yearend
Feb 10, 2021, 08:30
News
IR
English
Corporate Information
Other Corporate Information
Feb 10, 2021, 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Feb 04, 2021, 08:30
News
IR
English
Corporate Information
Other Corporate Information
Feb 04, 2021, 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Feb 03, 2021, 08:14
News
IR
Swedish
Regulatory
MAR
Corporate Information
Sales
Order
Feb 02, 2021, 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Feb 02, 2021, 08:30
News
IR
English
Corporate Information
Other Corporate Information
Feb 01, 2021, 08:30
News
IR
English
Corporate Information
Other Corporate Information
Feb 01, 2021, 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Jan 27, 2021, 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Jan 19, 2021, 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Possessing a unique combination
of engineering and pharmaceutical expertise, Iconovo can provide the optimal combination of uniquely designed inhalers and tailored formulations
ICONOVO AB
VISITING ADDRESS
Medicon Village, Lund
Scheeletorget 1, Bld 406
POSTAL ADDRESS
Iconovo AB
Medicon Village
SE-223 81 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
VP Business Development
Roger Lassing
Mail: roger.lassing@iconovo.se
CEO
Johan Wäborg
Mail: johan.waborg@iconovo.se